These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3570271)

  • 1. [Preparation of capsules of microencapsulated indomethacin and their bioavailability in rabbits].
    Lu B; Zhang L; Deng YH
    Hua Xi Yi Ke Da Xue Xue Bao; 1986 Dec; 17(4):328-31. PubMed ID: 3570271
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation of sustained-release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits.
    Nakajima T; Takashima Y; Iida K; Mitsuta H; Furuya A; Koishi M
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4249-54. PubMed ID: 3435949
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioavailability of indomethacin capsules in humans. (I): Bioavailability and effects of gastric acidity.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):469-74. PubMed ID: 4055157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the bioavailability of sustained-release indomethacin capsules].
    Li D; Yang XY; Wang JP; Wang YM; Shan J; Zhang HL; Bai YZ; Tao XH; Mo SY
    Yao Xue Xue Bao; 1985 May; 20(5):387-91. PubMed ID: 4083026
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioavailability of indomethacin capsules in humans (III): Correlation with bioavailability in beagle dogs.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A; Nakata H; Tsutsumi J; Fujita T; Amada I
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):578-84. PubMed ID: 4077308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of pharmacokinetics of indomethacin in man under consideration of bioavailability.
    Hippius M; Reinicke C
    Agents Actions Suppl; 1982; 10():109-17. PubMed ID: 6956211
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation of sustained-release suppositories of indomethacin using a solid dispersion system and evaluation of bioavailability in rabbits.
    Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K
    Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2999-3004. PubMed ID: 3769103
    [No Abstract]   [Full Text] [Related]  

  • 8. Microencapsulation and bioavailability in beagle dogs of indomethacin.
    Takeda Y; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1981 Jan; 29(1):264-7. PubMed ID: 7261196
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioavailability of indomethacin capsules in humans (II): correlation with dissolution rate.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):529-34. PubMed ID: 4066077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on sustained-release dosage forms. I. Preparation and bioavailability of indomethacin suppositories.
    Umeda T; Matsuzawa A; Yokoyama T; Kuroda K; Kuroda T
    Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2793-8. PubMed ID: 6652823
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of indomethacin in man.
    Baer JE; Hucker HB; Duggan DE
    Ann Clin Res; 1974; 6(0):suppl 11:44-7. PubMed ID: 4211834
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioavailability of indomethacin tablets in men volunteers.
    Groth PE; Dunn JM
    Clin Pharm; 1986 Oct; 5(10):820-4. PubMed ID: 3780150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmaceutical evaluation of a hollow type suppository. III. Effect of macrogol 300 on the bioavailability of indomethacin in rabbits].
    Watanabe Y; Tone Y; Suzuki M; Matsumoto M
    Yakugaku Zasshi; 1985 Mar; 105(3):284-8. PubMed ID: 4032233
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biopharmaceutical studies on indomethacin. II. Mechanism of intestinal absorption of indomethacin in rat in vitro and availability of micronized powder after oral administration to man].
    Fuwa T; Iga T; Hanano M; Nogami H; Kashima M
    Yakugaku Zasshi; 1971 Nov; 91(11):1223-7. PubMed ID: 5169130
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of indomethacin from a modified release system containing indomethacin as the lysine salt.
    Marzo A; Reiner A; Arrigoni Martelli E; Conte U; Colombo P; La Manna A
    Eur J Clin Pharmacol; 1987; 32(1):85-7. PubMed ID: 3108010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of food and repeated dosing on the bioavailability of indomethacin from a multiple-units controlled-release formulation.
    Skinhøj A; Bechgaard H; Chasseaud LF; Brodie RR; Sharman JM; Taylor T; Hunter JO
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):557-61. PubMed ID: 6511132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of oral and intravenous indomethacin dispositions in the premature infant with patent ductus arteriosus.
    Evans M; Bhat R; Vidyasagar D; Patel M; Hastreiter A
    Pediatr Pharmacol (New York); 1981; 1(3):251-8. PubMed ID: 7346745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic evaluation of indomethacin nanocapsules.
    Andrieu V; Fessi H; Dubrasquet M; Devissaguet JP; Puisieux F; Benita S
    Drug Des Deliv; 1989 Jun; 4(4):295-302. PubMed ID: 2775449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioavailability and tolerance of indomethacin as polymeric mini-capsules in man].
    Maboundou CW; Paintaud G; Ottignon Y; Magnette J; Bechtel Y; Fessi H; Gouchet F; Carayon P; Bechtel P
    Therapie; 1996; 51(1):88-9. PubMed ID: 8762227
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of sustained release on the pharmacokinetic profile of indomethacin in man.
    Yeh KC; Berger ET; Breault GO; Lei BW; McMahon FG
    Biopharm Drug Dispos; 1982; 3(3):219-30. PubMed ID: 7139063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.